These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22895897)

  • 1. Up-regulation of human prostaglandin reductase 1 improves the efficacy of hydroxymethylacylfulvene, an antitumor chemotherapeutic agent.
    Yu X; Erzinger MM; Pietsch KE; Cervoni-Curet FN; Whang J; Niederhuber J; Sturla SJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):426-33. PubMed ID: 22895897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of complementary function reductase enzymes in colon cancer cells by dithiole-3-thione versus sodium selenite.
    Erzinger MM; Bovet C; Uzozie A; Sturla SJ
    J Biochem Mol Toxicol; 2015 Jan; 29(1):10-20. PubMed ID: 25179160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of acylfulvene- and illudin S-DNA adducts in cells with variable bioactivation capacities.
    Pietsch KE; van Midwoud PM; Villalta PW; Sturla SJ
    Chem Res Toxicol; 2013 Jan; 26(1):146-55. PubMed ID: 23227857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells.
    Woynarowska BA; Roberts K; Woynarowski JM; MacDonald JR; Herman TS
    Radiat Res; 2000 Oct; 154(4):429-38. PubMed ID: 11023607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cytotoxicity and induction of apoptosis in tumor and normal cells by hydroxymethylacylfulvene (HMAF).
    Woynarowska BA; Woynarowski JM; Herzig MC; Roberts K; Higdon AL; MacDonald JR
    Biochem Pharmacol; 2000 May; 59(10):1217-26. PubMed ID: 10736422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling patterns of glutathione reductase inhibition by the natural product illudin S and its acylfulvene analogues.
    Liu X; Sturla SJ
    Mol Biosyst; 2009 Sep; 5(9):1013-24. PubMed ID: 19668867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and enzymatic reductive activation of acylfulvene to isomeric cytotoxic reactive intermediates.
    Pietsch KE; Neels JF; Yu X; Gong J; Sturla SJ
    Chem Res Toxicol; 2011 Nov; 24(11):2044-54. PubMed ID: 21939268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ptgr1 expression is regulated by NRF2 in rat hepatocarcinogenesis and promotes cell proliferation and resistance to oxidative stress.
    Sánchez-Rodríguez R; Torres-Mena JE; Quintanar-Jurado V; Chagoya-Hazas V; Rojas Del Castillo E; Del Pozo Yauner L; Villa-Treviño S; Pérez-Carreón JI
    Free Radic Biol Med; 2017 Jan; 102():87-99. PubMed ID: 27867096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the role of stereochemistry in the activity of anticancer acylfulvenes: synthesis, reductase-mediated bioactivation, and cellular toxicity.
    Gong J; Neels JF; Yu X; Kensler TW; Peterson LA; Sturla SJ
    J Med Chem; 2006 Apr; 49(8):2593-9. PubMed ID: 16610802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114).
    Woynarowski JM; Napier C; Koester SK; Chen SF; Troyer D; Chapman W; MacDonald JR
    Biochem Pharmacol; 1997 Dec; 54(11):1181-93. PubMed ID: 9416969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of MGI 114 (HMAF) histiospecific toxicity in human tumor cell lines.
    Kelner MJ; McMorris TC; Montoya MA; Estes L; Uglik SF; Rutherford M; Samson KM; Bagnell RD; Taetle R
    Cancer Chemother Pharmacol; 1999; 44(3):235-40. PubMed ID: 10453725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug uptake and cellular targets of hydroxymethylacylfulvene (HMAF).
    Herzig MC; Arnett B; MacDonald JR; Woynarowski JM
    Biochem Pharmacol; 1999 Jul; 58(2):217-25. PubMed ID: 10423161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of HMAF (MGI-114) in the MV522 metastatic lung carcinoma xenograft model nonresponsive to traditional anticancer agents.
    Kelner MJ; McMorris TC; Estes L; Wang W; Samson KM; Taetle R
    Invest New Drugs; 1996; 14(2):161-7. PubMed ID: 8913837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depurinating acylfulvene-DNA adducts: characterizing cellular chemical reactions of a selective antitumor agent.
    Gong J; Vaidyanathan VG; Yu X; Kensler TW; Peterson LA; Sturla SJ
    J Am Chem Soc; 2007 Feb; 129(7):2101-11. PubMed ID: 17256933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of the antioxidant selenoenyzmes thioredoxin reductase and glutathione peroxidase to alkylation-mediated inhibition by anticancer acylfulvenes.
    Liu X; Pietsch KE; Sturla SJ
    Chem Res Toxicol; 2011 May; 24(5):726-36. PubMed ID: 21443269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of irofulven monotherapy and in combination with mitoxantrone or docetaxel against human prostate cancer models.
    Van Laar ES; Weitman S; MacDonald JR; Waters SJ
    Prostate; 2004 Apr; 59(1):22-32. PubMed ID: 14991863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units.
    Hidalgo M; Izbicka E; Eckhardt SG; MacDonald JR; Cerna C; Gomez L; Rowinsky EK; Weitman SD; Von Hoff DD
    Anticancer Drugs; 1999 Oct; 10(9):837-44. PubMed ID: 10587294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM-dependent CHK2 activation induced by anticancer agent, irofulven.
    Wang J; Wiltshire T; Wang Y; Mikell C; Burks J; Cunningham C; Van Laar ES; Waters SJ; Reed E; Wang W
    J Biol Chem; 2004 Sep; 279(38):39584-92. PubMed ID: 15269203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prostaglandin reductase 1 (PTGR1) on gastric carcinoma using lentivirus-mediated system.
    Yang S; Luo F; Wang J; Mao X; Chen Z; Wang Z; Guo F
    Int J Clin Exp Pathol; 2015; 8(11):14493-9. PubMed ID: 26823768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of antitumor hydroxymethylacylfulvene by rat liver cytosol.
    McMorris TC; Elayadi AN; Yu J; Hu Y; Kelner MJ
    Drug Metab Dispos; 1999 Sep; 27(9):983-5. PubMed ID: 10460795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.